The strength of evidence regarding the effects of intermittent fasting on weight and cardiometabolic risk factors is weak compared to the strong, consistent evidence for the health benefits of a Mediterranean dietary pattern (Dinu et al
It combines GLP-1 and GIP receptor agonists, leading to improved insulin activity and reduced appetite
Accessed: 11.14.25 from: Wong, N, Karthikeyan, H, & FAN, W
Advertised Pricing Accuracy Perfect The prices advertised on social media appear to match the actual prices on the website
In the obesity group, there was a significant and clinically meaningful reduction in body weight of 4.74% at week 8, with weight continuously decreasing during the 8-week treatment period
The GLP-1R is a class B1 G protein-coupled receptor (GPCR) that mediates its effects via coupling to heterotrimeric G proteins 1